drugset / Trial / NCT00099086
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
This phase I trial is studying the side effects and best dose of docetaxel when given with radiation therapy and hormone therapy in patients with locally advanced prostate cancer.
Timeline
- Start
- 2007-01-16
- Primary completion
- 2011-01-20
- Completion
- 2023-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 10 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 15 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 20 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 25 mg/m2 | — |
| Background | Bicalutamide | Other / unclassified | — | — |
| Background | Goserelin | Other / unclassified | — | — |
| Background | Leuprolide | Other / unclassified | — | — |